Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.590
-0.010 (-1.68%)
At close: Oct 24, 2024, 4:00 PM
0.580
-0.010 (-1.68%)
After-hours: Oct 24, 2024, 5:07 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $23.67 million as of October 24, 2024. Its market cap has decreased by -42.12% in one year.
Market Cap
23.67M
Enterprise Value
-3.64M
1-Year Change
-42.12%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $23.67M, a decrease of -90.77%. That is a compound annual growth rate of -54.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 24.10M | -57.19% |
| Dec 29, 2023 | 56.30M | 11.93% |
| Dec 30, 2022 | 50.30M | -63.89% |
| Dec 31, 2021 | 139.30M | -45.68% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Athira Pharma | 20.33M |
| NEXGEL | 20.32M |
| NeurAxis | 20.24M |
| bioAffinity Technologies | 19.56M |
| Indaptus Therapeutics | 19.45M |
| Can-Fite BioPharma | 18.98M |
| Nexalin Technology | 18.95M |
| Sol-Gel Technologies | 18.66M |